XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Equity
6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement [Abstract]  
Stockholders' Equity
10.
Stockholders’ Equity

Stock Options

During the six months ended June 30, 2022, the Company had the following activities under its equity incentive plans:

 

 

 

 

Available
for Grant

 

 

Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate
Intrinsic Value

 

Balance at December 31, 2021

 

 

5,641,782

 

 

 

6,767,895

 

 

$

19.14

 

 

 

 

 

 

 

 

Shares authorized

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted (1)

 

 

(2,098,105

)

 

 

1,402,398

 

 

 

27.94

 

 

 

 

 

 

 

 

Exercised (2)

 

 

 

 

 

(693,988

)

 

 

10.47

 

 

 

 

 

 

 

 

Forfeited and expired

 

 

256,874

 

 

 

(256,874

)

 

 

43.56

 

 

 

 

 

 

 

Outstanding at June 30, 2022

 

 

3,800,551

 

 

 

7,219,431

 

 

$

20.81

 

 

 

6.08

 

 

$

72,849,218

 

Vested and expected to vest, net of estimated forfeiture
   at June 30, 2022

 

 

 

 

 

6,904,798

 

 

$

20.25

 

 

 

5.94

 

 

$

72,382,158

 

Exercisable at June 30, 2022

 

 

 

 

 

4,733,359

 

 

$

14.10

 

 

 

4.58

 

 

$

67,465,870

 

 

(1)
The difference between shares granted in the number of shares available for grant and outstanding options represents the RSUs and RSAs granted for the period with a 1.5 share ratio reduction to the reserve shares for each RSU or RSA grant in accordance with the amended and restated 2012 Equity Incentive Award Plan.
(2)
Shares presented as available for grant represents shares repurchased for tax withholding upon vesting of RSUs.

 

Restricted Stock

During the six months ended June 30, 2022, the activity for restricted stock is summarized as follows:

 

 

 

Shares

 

 

Weighted
Average
Grant-Date
Fair Value

 

Balance at December 31, 2021

 

 

413,510

 

 

$

45.94

 

Granted

 

 

463,803

 

 

 

28.29

 

Vested

 

 

(245,840

)

 

 

37.28

 

Unvested at June 30, 2022

 

 

631,473

 

 

$

36.34

 

Stock-based Compensation

Total stock-based compensation expense was $8.1 million and $17.6 million during the three and six months ended June 30, 2022, and $7.7 million and $15.8 million during the same periods ended June 30, 2021. As of June 30, 2022, $49.3 million, $15.4 million and $0.2 million of total unrecognized compensation expenses associated with outstanding employee stock options, unvested restricted stock, and the ESPP, net of estimated forfeitures, respectively, were expected to be recognized over a weighted-average period of 2.8, 2.6 and 0.4 years, respectively.